An anti-COVID oral drug developed by the Defence Research and Development Organisation has been approved by the Drugs Controller General of India for emergency use as an adjunct therapy in moderate......
Global brokerage CLSA has lowered its target price for IndusInd Bank from Rs 1,200 to Rs 900 while maintaining an outperform rating on the stock after the private lender disclosed a net worth hit......
In 2025, Indian firms may face higher premiums for fire and engineering insurance covers as reinsurers are likely to revise rates due to rising claims from catastrophic events and higher loss......
To signify its revamped and enlarged role in the field of education in the banking and financial sectors, the 75-year old Indian Institute of Bankers would be known as Indian Institute of Banking......
Despite a largely stable December quarter, investors booked profit in shares of IndusInd Bank (IIB) as an increase in slippages took them by surprise. Analysts, on their part, believe investors......
Banks enjoyed an expansion in Net Interest Margins (or NIMs) as well as in credit demand through the 2022-23 financial year (FY23). The credit expansion was because economic growth continued to......